Novartis
The companies will be looking at the real-world data from treatment with BRAF and MEK inhibitors.
The initiative will support the NHS in its recovery as it navigates the COVID-19 pandemic.
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.
At a recent online event, Novartis Chief Digital Officer Betrand Bodson gave an update on a digital strategy that began in 2018.
The new expansion is linked to a partnership the digital health company has with Novartis.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
Also: TapestryHealth purchases its telehealth tech vendor; Tech professionals eyeing healthcare and pharma jobs with new interest after COVID-19.
Also: HHS awards $20 million in telehealth access, infrastructure funds; Lumi launches online service.
Alongside the purchase of Amblyotech, the pharma company announced upcoming collaborations with major video game publisher Ubisoft and McGill University.